Published in Clin Immunol Immunopathol on November 01, 1986
Somatostatin analogues suppress the inflammatory reaction in vivo. J Clin Invest (1994) 1.16
Scintigraphic imaging of small-cell lung cancer with [111In]pentetreotide, a radiolabelled somatostatin analogue. Br J Cancer (1994) 0.77
Steady-state and dynamic properties of cardiac sodium-calcium exchange. Sodium-dependent inactivation. J Gen Physiol (1992) 1.92
Myeloproliferative virus, a cloned murine sarcoma virus with spleen focus-forming properties in adult mice. J Virol (1980) 1.85
[Evidence for tumor immunity in human malignant melanoma]. Schweiz Med Wochenschr (1970) 1.13
Differential gamma-interferon response of human colon carcinoma cells: inhibition of proliferation and modulation of immunogenicity as independent effects of gamma-interferon on tumor cell growth. Cancer Res (1985) 1.11
Diagnostic procedures in tularaemia with special focus on molecular and immunological techniques. J Vet Med B Infect Dis Vet Public Health (2005) 1.09
[The diagnostic validity of non-invasive pancreatic function tests--a meta-analysis]. Z Gastroenterol (2004) 1.07
Effects of myeloproliferative sarcoma virus on the pluripotential stem cell and granulocyte precursor cell populations of DBA/2 mice. J Natl Cancer Inst (1981) 1.02
Serum-to-urinary prostate-specific antigen ratio in patients with benign prostatic hyperplasia and prostate cancer. Anticancer Res (2001) 1.00
Action of temperature-sensitive mutants of myeloproliferative sarcoma virus suggests that fibroblast-transforming and hematopoietic transforming viral properties are related. J Virol (1984) 0.96
Cardiac Na(+)-Ca2+ exchange system in giant membrane patches. Ann N Y Acad Sci (1991) 0.94
Distribution and metabolism of hexadecylphosphocholine in mice. Lipids (1987) 0.94
Hexadecylphosphocholine induces interferon-gamma secretion and expression of GM-CSF mRNA in human mononuclear cells. Cell Immunol (1992) 0.91
Aminoglutethimide-induced hematologic toxicity: worldwide experience. Cancer Treat Rep (1985) 0.91
Severe hypophosphatemia during hematopoietic reconstitution after allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant (2000) 0.90
609 C --> T polymorphism in NAD(P)H:quinone oxidoreductase gene in patients with prostatic adenocarcinoma or benign prostatic hyperplasia. Cancer Lett (1999) 0.89
Severe granulomatous giant cell myocarditis in Wegener's granulomatosis. Klin Wochenschr (1990) 0.89
Autologous marrow recovery following allogeneic marrow transplantation in a patient with severe aplastic anemia. Exp Hematol (1976) 0.89
Predicting the risk of early atherosclerotic disease development in children after repair of aortic coarctation. Eur Heart J (2004) 0.87
Splenic function after splenectomy for trauma. Role of autotransplantation and splenosis. Acta Chir Scand (1989) 0.87
Hyperprolactinemia is an indicator of progressive disease and poor prognosis in advanced breast cancer. Int J Cancer (1984) 0.86
Double-blind randomised trial of the antiemetic efficacy and safety of ondansetron and metoclopramide in advanced breast cancer patients treated with epirubicin and cyclophosphamide. Eur J Cancer (1991) 0.86
Tumor necrosis factor (TNF) alpha: control of TNF-sensitivity and molecular mechanisms of TNF-mediated growth inhibition. Blut (1987) 0.86
Phenol sulphotransferase SULT1A1 polymorphism in prostate cancer: lack of association. Arch Toxicol (2000) 0.86
Heat shock response is associated with protection against acute interstitial pancreatitis in rats. Dig Dis Sci (2000) 0.85
Pharmacokinetic and pharmacodynamic basis for the treatment of metastatic breast cancer with high-dose medroxyprogesterone acetate. Cancer (1984) 0.85
5-Fluorouracil/irinotecan induced lethal toxicity as a result of a combined pharmacogenetic syndrome: report of a case. J Clin Pathol (2005) 0.84
Aminoglutethimide in the treatment of premenopausal patients with metastatic breast cancer. Eur J Cancer Clin Oncol (1986) 0.84
The mixed lymphocyte tumor cell culture and the fluorescein diacetate cytotoxicity test. Two useful methods for the demonstration of cell mediated tumor specific immunity in man. Acta Haematol (1970) 0.84
Evidence for tumor-specific immunity in human malignant melanoma. Eur J Cancer (1971) 0.83
[Propafenon-induced cholestatic liver injury--a further example for allergic drug hepatitis (author's transl)]. Z Gastroenterol (1981) 0.83
Cell-mediated immunity against malignant melanoma in monozygous twins. Cancer Res (1970) 0.83
Antiinflammatory agent BW 755 C in ischemic reperfused porcine hearts. J Cardiovasc Pharmacol (1988) 0.83
Diagnostic value of urinary alanine aminopeptidase and N-acetyl-beta-D-glucosaminidase in comparison to alpha 1-microglobulin as a marker in evaluating tubular dysfunction in glomerulonephritis patients. Clin Chim Acta (2000) 0.83
Calpain activation contributes to oxidative stress-induced pancreatic acinar cell injury. Biochem Pharmacol (2005) 0.82
Advantages of isovolemic large-volume erythrocytapheresis as a rapidly effective and long-lasting treatment modality for red blood cell depletion in patients with polycythemia vera. Ther Apher (1997) 0.82
Identification of lymphocyte subpopulations by simultaneous E-rosette formation and unspecific acid esterase staining. Experientia (1978) 0.82
[Determination of the carcinoembryonic antigen (CEA) for predicting the success of therapy in metastatic breast cancer]. Dtsch Med Wochenschr (1983) 0.82
The pharmacokinetics of high-dose medroxyprogesterone acetate (MPA) in the therapy of advanced breast cancer. Cancer Chemother Pharmacol (1982) 0.82
Detection of metastasis-associated differences for receptors of glycoconjugates (lectins) in histomorphologically unchanged xenotransplants from primary and metastatic lesions of human colon adenocarcinomas. Clin Exp Metastasis (1989) 0.81
Complement activation and depletion during LDL-apheresis by heparin-induced extracorporeal LDL-precipitation (HELP). Eur J Clin Invest (1991) 0.81
Effect of microenvironment and cell-line type on carbohydrate-binding proteins of macrophage-like cells. Biochem Cell Biol (1988) 0.81
Pattern of endogenous lectins in a human epithelial tumor. Cancer Res (1985) 0.81
[Immunosuppression: a paraneoplastic syndrome]. Schweiz Med Wochenschr (1971) 0.81
[Blood-brain barrier and the penetration of cytostatic drugs]. Klin Wochenschr (1985) 0.80
Effect of HELP-LDL-apheresis on serum concentrations of human lipoprotein(a): kinetic analysis of the post-treatment return to baseline levels. Eur J Clin Invest (1989) 0.80
[Humoral and cellular immune phenomena in pseudo-lupus-erythematosus (proceedings)]. Immun Infekt (1976) 0.80
Mitomycin-induced haemolysis and renal failure. Lancet (1980) 0.80
Contamination of fresh-frozen plasma with viable white cells and proliferable stem cells. Transfusion (1994) 0.80
Intra-arterial perfusion therapy with 5-fluorouracil in patients with metastatic colorectal carcinoma and intractable pelvic pain. Recent Results Cancer Res (1983) 0.79
[Metastasizing adenocarcinoma from an unknown primary tumor]. Dtsch Med Wochenschr (1984) 0.79
Binding characteristics of three complement dependent assays for the detection of immune complexes in human serum. J Clin Lab Immunol (1985) 0.79
Aminoglutethimide. Penetration of the blood brain barrier. Invest New Drugs (1986) 0.79
Acute and long-term effects of low-density lipoprotein apheresis on the serum concentrations of vitamins E and A. Klin Wochenschr (1988) 0.79
Phase II study of aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer. Cancer Res (1982) 0.79
Increased red blood cell adhesiveness/aggregation owing to fibrinogen elevation in hypercholesterolaemic patients and the rationale of fibrinogen-lowering by LDL apheresis. Eur J Clin Invest (2004) 0.79
Oxidative stress during dialysis: effect on free radical scavenging enzyme (FRSE) activities and glutathione (GSH) concentration in granulocytes. Nephrol Dial Transplant (1998) 0.79
Clinical significance of immunopathological findings in patients with post-pericardiotomy syndrome. II. The significance of serum inhibition and rosette inhibitory factors. Clin Exp Immunol (1979) 0.78
Determination of lipid hydroperoxides in serum iodometry and high performance liquid chromatography compared. Eur J Clin Chem Clin Biochem (1992) 0.78
Stimulation of human hematopoietic progenitor cells by the alkylphosphocholines hexadecylphosphocholine and hexadecyl-N,N,N-trimethyl-hexanolamine. Anticancer Res (2000) 0.78
The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. I. Evaluation of safety and cholesterol-lowering effects during the first 12 months. HELP Study Group. Eur J Clin Invest (1991) 0.78
Chromatofocusing combined with the ELISA technique. A sensitive method for the analysis of immune complexes. J Immunol Methods (1983) 0.78
[Bromocriptine in chemotherapy-resistant, metastatic breast cancer. Results of the GO-MC-BROMO 2/82 AIO Study]. Onkologie (1988) 0.78
[Thrombocytosis in malignant tumors]. Schweiz Med Wochenschr (1973) 0.78
Review: the oxidant/antioxidant balance during regular low density lipoprotein apheresis. Ther Apher (1999) 0.78
[Immune reactions in pseudo-lupus-syndrome. A long-term study (author's transl)]. Klin Wochenschr (1980) 0.78
Differential expression of endogenous sugar-binding proteins (lectins) in murine tumor model systems with metastatic capacity. Int J Cancer (1987) 0.78
Comparison of CD34+ cell numbers and colony growth before and after cryopreservation of peripheral blood progenitor and stem cell harvests: influence of prior chemotherapy. Transfusion (1997) 0.78
Hexadecylphosphocholine (D 18506) in the topical treatment of skin metastases: a phase-I trial. Onkologie (1988) 0.78
[1st experiences with Adriamycin, a new cytotoxic antibiotic, in combination chemotherapy of malignant tumors]. Schweiz Med Wochenschr (1972) 0.78
Plasma lipids are not oxidized during hemodialysis. Nephron (1994) 0.78
Acute treatment with vitamin E does not protect the regionally ischemic, reperfused porcine heart. Basic Res Cardiol (1991) 0.78
Heparin extracorporeal LDL precipitation (HELP): an effective apheresis procedure for lowering Lp(a) levels. Chem Phys Lipids (1994) 0.77
[Chronic granulocytopenia as a main symptom of T gamma-lymphocytosis]. Dtsch Med Wochenschr (1989) 0.77
[Mucin-like carcinoma-associated antigen: sensitivity and specificity in metastatic breast cancer]. Onkologie (1990) 0.77
Biological and biochemical characterization of a somatostatin-producing human carcinoma established by heterotransplantation. Cancer Res (1985) 0.77
The topography of non-linear cortical dynamics at rest, in mental calculation and moving shape perception. Brain Topogr (1998) 0.77
Chemiluminescence of polymorphonuclear granulocytes in the presence of selected Candida species. Mycoses (1993) 0.77
Carbohydrate-binding proteins of tumor lines with different growth properties. II. Changes in their pattern in clones of transformed rat fibroblasts of differing metastatic potential. Cell Tissue Res (1986) 0.77
A prospective, randomized, sequential, crossover trial of large-volume versus normal-volume leukapheresis procedures: effect on progenitor cells and engraftment. Transfusion (1999) 0.77
Sustained remission of chronic hepatitis C after a change to human leukocyte interferon-alpha in a difficult-to-treat patient with breakthrough phenomenon associated with antibodies against recombinant interferon-alpha. Am J Gastroenterol (2001) 0.77
Effect of ether lipids on mouse granulocyte-macrophage progenitor cells. Cancer Chemother Pharmacol (1989) 0.77
Characterization of immune complexes detected by the 125I-C1q binding assay in breast cancer. Clin Immunol Immunopathol (1988) 0.77
Failure of iloprost to protect the regionally ischemic, reperfused porcine heart. J Mol Cell Cardiol (1991) 0.77
[Prophylaxis and therapy of cytostatic-induced skin necrosis]. Onkologie (1980) 0.77
Immediate and late effects of coronary angiography on soluble endothelial cell markers and P-selectin in patients with and without coronary artery disease. Blood Coagul Fibrinolysis (1999) 0.76
Use of recombinant human granulocyte-macrophage colony stimulating factor in T-lymphocytosis with granulocytopenia. Eur J Haematol (1990) 0.76
Acute effect of H.E.L.P. treatment on radical scavenging enzyme activities, total glutathione concentrations in granulocytes, and selenium in plasma. Eur J Clin Invest (2000) 0.76
Platelet serotonin acts as a locally releasable antioxidant. Adv Exp Med Biol (1996) 0.76
Malignant lymphoma in four of five siblings. Int J Cancer (1978) 0.76
Suppression of leukocyte-enhanced cold ischemia/reperfusion injury of liver endothelium with the benzoquinone antioxidant idebenone. Clin Biochem (1997) 0.76
Calpain mediates caspase-dependent apoptosis initiated by hydrogen peroxide in pancreatic acinar AR42J cells. Free Radic Res (2013) 0.76
Intralesional application of recombinant human tumor necrosis factor alpha induces local tumor regression in patients with advanced malignancies. Eur J Cancer Clin Oncol (1989) 0.76
Long-term experience with the HELP system for treatment of severe familial hypercholesterolemia. ASAIO Trans (1987) 0.76
Cytotoxic activity of lysophosphatidylcholine analogues on human lymphoma Raji cells. Onkologie (1990) 0.76